Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin effect on mirror system in ASD
NCT03640156Phase 3Completed
- Sponsor
- KU Leuven
- Start
- Jul 2018
- Primary completion
- Dec 2019
- Countries
- 1
01
Overview
A Phase 3 trial of oxytocin nasal spray in Autism Spectrum Disorder (ASD), sponsored by KU Leuven. Started Jul 2018; status: completed.
02
Drugs
oxytocin nasal spray
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT03640156.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03640156.